Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 13,923 | 14,749 | 18,400 | 15,526 | 17,603 |
| Cost of Goods | 7,706 | 8,755 | 11,299 | 9,670 | 10,800 |
| Gross Profit | 6,217 | 5,994 | 7,100 | 5,856 | 6,804 |
| Operating Expenses | 4,469 | 4,574 | 4,621 | 4,733 | 5,005 |
| Operating Income | 2,454 | 2,174 | 2,778 | 1,793 | 2,598 |
| Interest Expense | 120 | 103 | 112 | 104 | 114 |
| Other Income | 86 | 22 | 19 | 44 | 32 |
| Pre-tax Income | 2,421 | 2,094 | 2,685 | 1,733 | 2,517 |
| Income Tax | 728 | 634 | 698 | 474 | 669 |
| Net Income Continuous | 1,693 | 1,460 | 1,988 | 1,259 | 1,848 |
| Minority Interests | -51 | -56 | -10 | -10 | -16 |
| Net Income | $1,744 | $1,515 | $1,998 | $1,269 | $1,864 |
| EPS Basic Total Ops | 0.06 | 0.05 | 0.08 | 0.04 | 0.06 |
| EPS Basic Continuous Ops | 0.06 | 0.05 | 0.07 | 0.04 | 0.06 |
| EPS Diluted Total Ops | 0.06 | 0.05 | 0.08 | 0.04 | 0.06 |
| EPS Diluted Continuous Ops | 0.06 | 0.05 | 0.07 | 0.04 | 0.06 |
| EBITDA(a) | $3,104 | $2,822 | $3,422 | $2,413 | $3,186 |